Home > Compound List > Product Information
Gadobutrol_Molecular_structure_CAS_138071-82-6)
Click picture or here to close

Gadobutrol

Catalog No. DB06703 Name DrugBank
CAS Number 138071-82-6 Website http://www.ualberta.ca/
M. F. C18H31GdN4O9 Telephone (780) 492-3111
M. W. 604.71014 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 4441

SYNONYMS

IUPAC name
gadolinium(3+) ion 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
IUPAC Traditional name
gadolinium(3+) 2-[4,7-bis(carboxylatomethyl)-10-(1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecan-1-yl]acetate
Brand Name
Gadovist

DATABASE IDS

PubChem SID 99443257
CAS Number 138071-82-6
PubChem CID 15814656

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description Gadobutrol is a contrast agent used in magnetic resonance imaging (MRI).
Indication For diagnostic use only. Indicated for adults and children, age 2 and over, for contrast enhancement during cranial and spinal MRI and for contrast-enhanced magnetic resonance angiography (CE-MRA). Gadobutrol is particularly suited for where the exclusion or demonstration of additional pathology may influence the choice of therapy or patient management, for detection of very small lesions and for visualization of tumors that do not readily take up contrast media. May also be suitable for perfusion studies for the diagnosis of stroke, detection of focal cerebral ischemia and tumor perfusion.
External Links
Wikipedia

REFERENCES